IperionX Limited Sponsored ADR (NASDAQ:IPX) Given Consensus Rating of “Moderate Buy” by Brokerages

IperionX Limited Sponsored ADR (NASDAQ:IPXGet Free Report) has received a consensus recommendation of “Moderate Buy” from the five ratings firms that are presently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation and four have given a buy recommendation to the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $55.3333.

Several research analysts have weighed in on the stock. BTIG Research assumed coverage on shares of IperionX in a research note on Friday. They set a “buy” rating and a $40.00 target price for the company. William Blair started coverage on shares of IperionX in a report on Tuesday, January 13th. They issued an “outperform” rating on the stock. Roth Mkm reiterated a “buy” rating and issued a $74.00 target price on shares of IperionX in a report on Tuesday, January 20th. Weiss Ratings restated a “sell (e+)” rating on shares of IperionX in a research note on Thursday, January 22nd. Finally, B. Riley Financial dropped their price objective on IperionX from $58.00 to $52.00 and set a “buy” rating for the company in a research note on Friday, March 13th.

Check Out Our Latest Research Report on IperionX

IperionX Price Performance

Shares of IperionX stock opened at $21.98 on Friday. The stock has a 50 day moving average of $43.19 and a 200 day moving average of $42.36. The company has a current ratio of 4.03, a quick ratio of 4.00 and a debt-to-equity ratio of 0.03. IperionX has a fifty-two week low of $12.27 and a fifty-two week high of $61.45.

IperionX (NASDAQ:IPXGet Free Report) last announced its quarterly earnings results on Friday, January 30th. The company reported ($0.50) EPS for the quarter. As a group, sell-side analysts forecast that IperionX will post -0.08 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Thomist Capital Management LP acquired a new position in shares of IperionX in the second quarter valued at approximately $59,384,000. Van ECK Associates Corp purchased a new position in IperionX in the 3rd quarter valued at approximately $40,997,000. Millennium Management LLC acquired a new position in shares of IperionX in the fourth quarter worth $4,249,000. Jane Street Group LLC increased its position in shares of IperionX by 62.5% during the fourth quarter. Jane Street Group LLC now owns 129,020 shares of the company’s stock worth $4,669,000 after acquiring an additional 49,645 shares during the period. Finally, Bank of America Corp DE raised its stake in shares of IperionX by 69.0% in the second quarter. Bank of America Corp DE now owns 35,441 shares of the company’s stock valued at $1,116,000 after acquiring an additional 14,467 shares in the last quarter. Hedge funds and other institutional investors own 2.76% of the company’s stock.

About IperionX

(Get Free Report)

IperionX (NASDAQ: IPX) is a mineral technology company focused on the production and commercialization of high‐purity titanium and zirconium products. The company’s core activities include the development of advanced mineral sands projects and the deployment of proprietary processing technologies aimed at supplying feedstocks to aerospace, defense, additive manufacturing and battery markets.

At the heart of IperionX’s operations is the Stony Creek Project in Virginia, where the company holds significant mineral sands rights.

Featured Articles

Analyst Recommendations for IperionX (NASDAQ:IPX)

Receive News & Ratings for IperionX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IperionX and related companies with MarketBeat.com's FREE daily email newsletter.